Literature DB >> 35248205

Neuromodulation of cognition in Parkinson's disease.

Rachel C Cole1, Derrick N Okine1, Brooke E Yeager1, Nandakumar S Narayanan2.   

Abstract

Neuromodulation is a widely used treatment for motor symptoms of Parkinson's disease (PD). It can be a highly effective treatment as a result of knowledge of circuit dysfunction associated with motor symptoms in PD. However, the mechanisms underlying cognitive symptoms of PD are less well-known, and the effects of neuromodulation on these symptoms are less consistent. Nonetheless, neuromodulation provides a unique opportunity to modulate motor and cognitive circuits while minimizing off-target side effects. We review the modalities of neuromodulation used in PD and the potential implications for cognitive symptoms. There have been some encouraging findings with both invasive and noninvasive modalities of neuromodulation, and there are promising advances being made in the field of therapeutic neuromodulation. Substantial work is needed to determine which modulation targets are most effective for the different types of cognitive deficits of PD.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Deep brain stimulation; Movement disorders; Nonmotor symptoms; Prefrontal cortex; Transcranial alternating current stimulation; Transcranial direct current stimulation; Transcranial magnetic stimulation

Mesh:

Year:  2022        PMID: 35248205      PMCID: PMC9199111          DOI: 10.1016/bs.pbr.2022.01.016

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.624


  107 in total

1.  Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold.

Authors:  James F Cavanagh; Thomas V Wiecki; Michael X Cohen; Christina M Figueroa; Johan Samanta; Scott J Sherman; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-09-25       Impact factor: 24.884

Review 2.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

3.  Differential effects of 10-Hz and 40-Hz transcranial alternating current stimulation (tACS) on endogenous versus exogenous attention.

Authors:  Joseph B Hopfinger; Jonathan Parsons; Flavio Fröhlich
Journal:  Cogn Neurosci       Date:  2016-06-14       Impact factor: 3.065

Review 4.  A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Authors:  Fabio Marson; Stefano Lasaponara; Marco Cavallo
Journal:  Medicina (Kaunas)       Date:  2021-02-27       Impact factor: 2.430

5.  Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease.

Authors:  Paulo S Boggio; Roberta Ferrucci; Sergio P Rigonatti; Priscila Covre; Michael Nitsche; Alvaro Pascual-Leone; Felipe Fregni
Journal:  J Neurol Sci       Date:  2006-07-14       Impact factor: 3.181

Review 6.  Deep brain stimulation for Parkinson's disease.

Authors:  Alim Louis Benabid
Journal:  Curr Opin Neurobiol       Date:  2003-12       Impact factor: 6.627

7.  Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.

Authors:  C C Chiueh; S P Markey; R S Burns; J N Johannessen; D M Jacobowitz; I J Kopin
Journal:  Psychopharmacol Bull       Date:  1984

Review 8.  Cognitive Impairment and Dementia in Parkinson Disease.

Authors:  Jennifer G Goldman; Erica Sieg
Journal:  Clin Geriatr Med       Date:  2020-01-23       Impact factor: 3.076

9.  Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.

Authors:  Mark S Baron; Thomas Wichmann; Demin Ma; Mahlon R DeLong
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

10.  Tremor suppression by rhythmic transcranial current stimulation.

Authors:  John-Stuart Brittain; Penny Probert-Smith; Tipu Z Aziz; Peter Brown
Journal:  Curr Biol       Date:  2013-02-14       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.